Traditional cell-free protein synthesis (CFPS) struggles with scalability and optimization. The I.DOT can unlock a new era of control and efficiency.
Experience unparalleled microfluidic control for your dose response curves with DISPENDIX's I.DOT Liquid Handler.
A promising new marker called APCDD1 has been identified that accurately identifies the right type of dopamine-producing cell precursors, paving the...
FLASH-seq redefines single-cell RNA sequencing: faster, more sensitive, and streamlines the process with I.DOT Liquid Handler.
Demystify drug discovery! Join our "Innovations in Drug Discovery" webinar & explore miniaturized protein engineering & open port mass spectrometry.
Traditional cancer research suffers from inaccurate 2D models. 3D bioprinting offers a revolution: print realistic tumor models for better drug...